Eight months after getting a $500,000 donation from an executive at Sam Bankman-Fried’s bankrupt cryptocurrency firm FTX, the Democratic Party of Oregon is surrendering the cash to federal authorities to comply with a request from the U.S. Department …
Author: Anthony Effinger
A $28 Million Low-Income Apartment Complex Descends Into Chaos in Just Two and a Half Years
At first glance, the Buri Building in the Hazelwood neighborhood looks like an ideal way to house some of the thousands of people living in tent camps around Portland.
How Federal Dollars Rescued the Rose Festival
As chief operating officer of the 116-year-old Portland Rose Festival, Marilyn Clint fought through a lot of dark days during the pandemic.
Clackamas County Commissioners Want to See if Voters Are Willing to Recriminalize Drugs
Are Clackamas County voters done with Oregon’s drug decriminalization law, passed in 2020?
Pile of Tire Shards Catches Fire for Third Day as Internal Heat Stays High Enough to Reignite
For the third time in six days, the massive pile of tire shards sitting beside an old grain elevator on the Willamette River reignited this morning, sending flames and smoke into the spring air.
City of Tigard Woos Portland Contractor Who Told WW About Difficulties With Portland Permitting
Fed up with building in Portland?
Wheeler Proposes Criminal Penalties for Camping, Lighting Fires Along City Streets
Camping on Portland streets is no picnic, and it’s about to get a lot harder.
Taxpayers May Soon Be Filling the Funding Gaps in Oregon’s Psilocybin System
So far, just three psilocybin service centers—offices where people can go on legal mushroom trips—have been licensed by the state of Oregon.
Synaptic Training Institute Won’t Open Psilocybin Service Center Because of “Cumbersome Process”
Synaptic Institute Inc., a Portland-based group that trains facilitators for psychedelic experiences, says it scrapped plans to open its own psilocybin service center because the process is too “cumbersome”.
Former Oregon Congressman Kurt Schrader Gets Job at Firm that Lobbies for Big Pharma
Six-term U.S. Rep.